CAPTRUST Financial Advisors
PROF

CAPTRUST Financial Advisors’s Profound Medical PROF Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.4K Buy
+10,398
New +$71.8K ﹤0.01% 2865
2022
Q3 		– Sell
-6,000
Closed -$44K – 3527
2022
Q2 		$44K Hold
6,000
– – ﹤0.01% 2850
2022
Q1 		$54K Hold
6,000
– – ﹤0.01% 2731
2021
Q4 		$67K Hold
6,000
– – ﹤0.01% 2447
2021
Q3 		$88K Sell
6,000
-100
-2% -$1.52K ﹤0.01% 2177
2021
Q2 		$100K Hold
6,100
– – ﹤0.01% 2029
2021
Q1 		$123K Hold
6,100
– – ﹤0.01% 1805
2020
Q4 		$125K Buy
+6,100
New +$112K ﹤0.01% 1404

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

CAPTRUST Financial Advisors's PROF Position: Q1 2026 in Review

CAPTRUST Financial Advisors opened a new position in Profound Medical (PROF) in Q1 2026: 10,398 shares worth $67.4K. The stake represents ﹤0.01% of the portfolio and ranks #2865 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in PROF as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in PROF in Q4 2020 and has held it in 8 quarters since. The position peaked at $125K in Q4 2020. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • CAPTRUST Financial Advisors held 10,398 shares of Profound Medical worth $67.4K as of Q1 2026.
  • Profound Medical was a new CAPTRUST Financial Advisors position in Q1 2026.
  • Profound Medical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2865 holding.
  • CAPTRUST Financial Advisors first reported a position in Profound Medical in Q4 2020 and has held it in 8 quarters since.
  • CAPTRUST Financial Advisors's Profound Medical position peaked at $125K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.